BlackRock’s Acer Therapeutics Inc. Common Stock (DE) ACER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-76,772
Closed -$62.6K 5416
2023
Q3
$62.6K Hold
76,772
﹤0.01% 4894
2023
Q2
$70.9K Sell
76,772
-26,200
-25% -$24.2K ﹤0.01% 4918
2023
Q1
$78.1K Sell
102,972
-16,048
-13% -$12.2K ﹤0.01% 4943
2022
Q4
$299K Buy
119,020
+194
+0.2% +$487 ﹤0.01% 4660
2022
Q3
$166K Sell
118,826
-1,279
-1% -$1.79K ﹤0.01% 4937
2022
Q2
$151K Buy
120,105
+17,065
+17% +$21.5K ﹤0.01% 5021
2022
Q1
$300K Sell
103,040
-1,269
-1% -$3.7K ﹤0.01% 4929
2021
Q4
$237K Buy
104,309
+705
+0.7% +$1.6K ﹤0.01% 4998
2021
Q3
$265K Sell
103,604
-564
-0.5% -$1.44K ﹤0.01% 4852
2021
Q2
$299K Buy
104,168
+10,530
+11% +$30.2K ﹤0.01% 4742
2021
Q1
$291K Hold
93,638
﹤0.01% 4615
2020
Q4
$245K Hold
93,638
﹤0.01% 4369
2020
Q3
$270K Sell
93,638
-73,158
-44% -$211K ﹤0.01% 4254
2020
Q2
$573K Sell
166,796
-222,930
-57% -$766K ﹤0.01% 4095
2020
Q1
$775K Sell
389,726
-3,178
-0.8% -$6.32K ﹤0.01% 3874
2019
Q4
$1.58M Sell
392,904
-7,593
-2% -$30.5K ﹤0.01% 3798
2019
Q3
$1.28M Buy
400,497
+68,944
+21% +$220K ﹤0.01% 3845
2019
Q2
$1.29M Buy
331,553
+311,590
+1,561% +$1.22M ﹤0.01% 3878
2019
Q1
$485K Buy
19,963
+10,055
+101% +$244K ﹤0.01% 4056
2018
Q4
$199K Sell
9,908
-683
-6% -$13.7K ﹤0.01% 4191
2018
Q3
$327K Buy
10,591
+2,805
+36% +$86.6K ﹤0.01% 4156
2018
Q2
$168K Buy
7,786
+7,418
+2,016% +$160K ﹤0.01% 4301
2018
Q1
$7K Hold
368
﹤0.01% 4643
2017
Q4
$5K Hold
368
﹤0.01% 4673
2017
Q3
$7K Buy
368
+30
+9% +$571 ﹤0.01% 4649
2017
Q2
$2K Buy
338
+49
+17% +$290 ﹤0.01% 4848
2017
Q1
$2K Buy
+289
New +$2K ﹤0.01% 4844